Abstract:Drug delivery systems efficiently and safely administer therapeutic agents to specific body sites. Liposomes, spherical vesicles made of phospholipid bilayers, have become a powerful tool in this field, especially with the rise of microfluidic manufacturing during the COVID-19 pandemic. Despite its efficiency, microfluidic liposomal production poses challenges, often requiring laborious, optimization on a case-by-case basis. This is due to a lack of comprehensive understanding and robust methodologies, compounded by limited data on microfluidic production with varying lipids. Artificial intelligence offers promise in predicting lipid behaviour during microfluidic production, with the still unexploited potential of streamlining development. Herein we employ machine learning to predict critical quality attributes and process parameters for microfluidic-based liposome production. Validated models predict liposome formation, size, and production parameters, significantly advancing our understanding of lipid behaviour. Extensive model analysis enhanced interpretability and investigated underlying mechanisms, supporting the transition to microfluidic production. Unlocking the potential of machine learning in drug development can accelerate pharmaceutical innovation, making drug delivery systems more adaptable and accessible.

What problem does this paper attempt to address?

The paper aims to address the following key issues: ### Key Issues 1. **Simplify the development process of liposomal drug delivery systems**: By utilizing machine learning techniques to predict the critical quality attributes (such as formation, size, etc.) and process parameters of liposomes during microfluidic production, the development of liposomal drug delivery systems can be simplified. ### Specific Objectives - **Address the challenges of microfluidic liposome production**: Although microfluidic liposome production is efficient, it requires tedious optimization work for each case. The paper attempts to overcome this challenge through machine learning methods. - **Predict lipid behavior**: Use artificial intelligence to predict the behavior of lipids during microfluidic production, particularly the formation, size, and production parameters of liposomes. - **Enhance interpretability**: Enhance the interpretability of the model through machine learning model analysis and explore potential mechanisms to support the transition to microfluidic production methods. - **Accelerate drug development**: Unlock the potential of machine learning in drug development to accelerate pharmaceutical innovation, making drug delivery systems more adaptive and accessible. - **Establish a reliable framework**: Establish a reliable framework that can transition from traditional liposome production methods to microfluidic technology, thereby simplifying the development of liposomal drug delivery systems, reducing reliance on empirical methods, and accelerating the optimization process. ### Research Background and Motivation - **Role of liposomes**: Liposomes, as an effective drug delivery system, play an important role in drug stability, parenteral administration, and controlled drug release. - **Advantages of microfluidic technology**: Compared to traditional production methods, microfluidic technology offers the possibility of precise control over the production process, generating liposomes with uniform size distribution and customized characteristics, which are crucial for consistent therapeutic effects. - **Challenges faced**: Despite the many advantages of microfluidic technology, there are still some obstacles in clinical and industrial applications, such as scaling up laboratory-scale production to industrial scale and the unique responses of different liposomal formulations to microfluidic conditions, which require extensive optimization work for each case. In summary, the main goal of this paper is to address the key challenges in the microfluidic liposome production process through machine learning techniques, with the aim of simplifying the development process of liposomal drug delivery systems and accelerating the drug development process.

Leveraging machine learning to streamline the development of liposomal drug delivery systems

Review of machine learning for lipid nanoparticle formulation and process development

Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers

Machine learning instructed microfluidic synthesis of curcumin-loaded liposomes

Machine Learning-guided Lipid Nanoparticle Design for mRNA Delivery

Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications

Transitioning the production of lipidic mesophase-based delivery systems from lab-scale to robust industrial manufacturing following a risk-based quality by design approach augmented by artificial intelligence

Machine learning models to accelerate the design of polymeric long-acting injectables

Machine learning in accelerating microsphere formulation development

Machine learning enhanced droplet microfluidics

Machine learning in drug delivery

Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm

Machine learning directed drug formulation development

Machine learning framework to predict the performance of lipid nanoparticles for nucleic acid delivery

A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology

Advanced Microfluidic Technologies for Lipid Nano-Microsystems from Synthesis to Biological Application

Design automation of microfluidic single and double emulsion droplets with machine learning

Scalable microfluidic method for tunable liposomal production by a design of experiment approach

A machine-learning-assisted study of the permeability of small drug-like molecules across lipid membranes

Mechanistic Modeling of Lipid Nanoparticle Formation for the Delivery of Nucleic Acid Therapeutics

Liposome production by microfluidics: potential and limiting factors